Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 426

    1.

    Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.

    Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL.

    Diabetes Care. 2002 Oct;25(10):1709-14.PMID: 12351466 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.

    Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B.

    Diabetes Care. 2001 Feb;24(2):228-33.PMID: 11213870 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women.

    Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP.

    J Clin Endocrinol Metab. 2001 Jul;86(7):3053-60.PMID: 11443167 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women.

    Washburn S, Burke GL, Morgan T, Anthony M.

    Menopause. 1999 Spring;6(1):7-13.PMID: 10100174 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.

    Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ.

    Menopause. 2007 Jul-Aug;14(4):624-9.PMID: 17290158 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women.

    Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ.

    Climacteric. 2000 Sep;3(3):161-7.PMID: 11910617 [PubMed - indexed for MEDLINE]Related articles

    7.

    A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium.

    Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM.

    J Soc Gynecol Investig. 2002 Jul-Aug;9(4):238-42.PMID: 12113884 [PubMed - indexed for MEDLINE]Related articles

    8.

    Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women.

    Garrido A, De la Maza MP, Hirsch S, Valladares L.

    Maturitas. 2006 Jun 20;54(3):270-6. Epub 2006 Jan 18.PMID: 16414215 [PubMed - indexed for MEDLINE]Related articles

    9.

    Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women.

    Scheiber MD, Liu JH, Subbiah MT, Rebar RW, Setchell KD.

    Menopause. 2001 Sep-Oct;8(5):384-92.PMID: 11528367 [PubMed - indexed for MEDLINE]Related articles

    10.

    Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.

    Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, Zunft HJ, Ferrari M, Branca F, Dadd T, Talbot D, Powell J, Minihane AM, Cassidy A, Nilsson M, Dahlman-Wright K, Gustafsson JA, Williams CM.

    Am J Clin Nutr. 2006 Mar;83(3):592-600.PMID: 16522905 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women.

    Dewell A, Hollenbeck CB, Bruce B.

    J Clin Endocrinol Metab. 2002 Jan;87(1):118-21.PMID: 11788633 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study.

    Kritz-Silverstein D, Von Mühlen D, Barrett-Connor E, Bressel MA.

    Menopause. 2003 May-Jun;10(3):196-202.PMID: 12792289 [PubMed - indexed for MEDLINE]Related articles

    15.

    A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

    Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

    Clin Ther. 2003 Apr;25(4):1074-95.PMID: 12809958 [PubMed - indexed for MEDLINE]Related articles

    16.

    Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.

    Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR.

    JAMA. 2003 Jul 9;290(2):207-14.PMID: 12851275 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    19.

    Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial.

    Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A.

    Diabetes Care. 2007 Nov;30(11):2804-10. Epub 2007 Aug 8.PMID: 17686832 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Phytoestrogens and cardiovascular disease.

    Cassidy A, Hooper L.

    J Br Menopause Soc. 2006 Jun;12(2):49-56. Review.PMID: 16776855 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data